Fermitin 2 Protein (Kindlin 2) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Fermitin-2, also known as Kindlin-2, is a member of the fermitin/kindlin family of proteins that play critical roles in integrin activation and cell-matrix adhesion. Fermitin-2 is widely expressed in various tissues including the brain, where it regulates integrin-mediated signaling important for neuronal survival and blood-brain barrier (BBB) function.[1]
Fermitin-2 is a 683 amino acid protein with a characteristic domain architecture:
The FERM domain binds to integrin β cytoplasmic tails, while the PH domain targets the protein to the plasma membrane.
Fermitin-2/Kindlin-2 performs essential functions:
FERMT2 has been identified as a genetic risk factor for late-onset Alzheimer's disease (LOAD) through GWAS.[3]
Disease Mechanisms:
Fermitin-2 is frequently overexpressed in various cancers and is associated with tumor progression and metastasis.
Strategies for targeting fermitin-2 in AD:
The study of Fermitin 2 Protein (Kindlin 2) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Fermitin family members in cell adhesion. PMID:19403593
References
[1] Rognoni E, et al. Kindlin-2: a novel regulator of integrin signaling. Cell Cycle. 2014;13(4):530-535.
[2] Ma YQ, et al. Kindlin-2 (Mig-2) regulates integrin activation. J Cell Sci. 2011;124(Pt 7):1043-1052.
[3] Lambert JC, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013;45(12):1452-1458.
[4] Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease. Nat Rev Neurosci. 2011;12(12):723-738.